维琪科技冲击“多肽原料第一股”,综合毛利率逐年下滑

新京报
26 Feb

随着维琪科技开启上市辅导,其面临的毛利率下降、经营业绩波动等风险进一步显现。2月24日,新京报贝壳财经记者获悉,深圳市维琪科技股份有限公司(以下简称“维琪科技”)完成IPO辅导备案,拟在北交所上市,辅导机构为国信证券。据辅导工作安排,国信证券拟于2025年4月-5月督促维琪科技整改尽职调查中发现的相关问题,并与监管机构就辅导工作进行全面沟通,申请并通过辅导验收。若维琪科技成功上市,将成为化妆品行业...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10